Dae Gon Ha
Stock Analyst at Stifel
(2.72)
# 2,110
Out of 5,033 analysts
46
Total ratings
39.47%
Success rate
9.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Dae Gon Ha
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MIRM Mirum Pharmaceuticals | Reinstates: Buy | $89 | $72.73 | +22.37% | 4 | Aug 11, 2025 | |
| ABEO Abeona Therapeutics | Maintains: Buy | $21 → $20 | $5.46 | +266.64% | 2 | May 16, 2025 | |
| EDIT Editas Medicine | Downgrades: Hold | $11 → $3 | $4.18 | -28.23% | 4 | Dec 13, 2024 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $59 → $74 | $65.11 | +13.65% | 2 | Oct 1, 2024 | |
| FULC Fulcrum Therapeutics | Downgrades: Hold | $22 → $3 | $9.15 | -67.21% | 4 | Sep 12, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $80 → $64 | $27.27 | +134.69% | 2 | Sep 11, 2024 | |
| KRYS Krystal Biotech | Maintains: Buy | $204 → $220 | $190.37 | +15.56% | 4 | Sep 11, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $124 → $127 | $34.04 | +273.09% | 2 | May 31, 2024 | |
| RCKT Rocket Pharmaceuticals | Reiterates: Buy | $48 | $3.89 | +1,133.93% | 4 | Sep 13, 2023 | |
| PRME Prime Medicine | Initiates: Buy | $18 | $6.04 | +198.26% | 1 | Apr 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $7 | $1.49 | +369.83% | 1 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $25 | $109.88 | -77.25% | 4 | Jun 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $16 | $8.34 | +91.85% | 3 | Nov 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $285 | $13.81 | +1,963.72% | 1 | Sep 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $20 | $2.97 | +573.40% | 1 | May 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $18.50 | - | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $26.55 | - | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $6.76 | - | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.24 | +867.74% | 1 | Jun 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $600 → $490 | $16.10 | +2,943.48% | 2 | Oct 23, 2017 |
Mirum Pharmaceuticals
Aug 11, 2025
Reinstates: Buy
Price Target: $89
Current: $72.73
Upside: +22.37%
Abeona Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $21 → $20
Current: $5.46
Upside: +266.64%
Editas Medicine
Dec 13, 2024
Downgrades: Hold
Price Target: $11 → $3
Current: $4.18
Upside: -28.23%
Soleno Therapeutics
Oct 1, 2024
Maintains: Buy
Price Target: $59 → $74
Current: $65.11
Upside: +13.65%
Fulcrum Therapeutics
Sep 12, 2024
Downgrades: Hold
Price Target: $22 → $3
Current: $9.15
Upside: -67.21%
Intellia Therapeutics
Sep 11, 2024
Maintains: Buy
Price Target: $80 → $64
Current: $27.27
Upside: +134.69%
Krystal Biotech
Sep 11, 2024
Maintains: Buy
Price Target: $204 → $220
Current: $190.37
Upside: +15.56%
Ultragenyx Pharmaceutical
May 31, 2024
Maintains: Buy
Price Target: $124 → $127
Current: $34.04
Upside: +273.09%
Rocket Pharmaceuticals
Sep 13, 2023
Reiterates: Buy
Price Target: $48
Current: $3.89
Upside: +1,133.93%
Prime Medicine
Apr 18, 2023
Initiates: Buy
Price Target: $18
Current: $6.04
Upside: +198.26%
Mar 24, 2023
Maintains: Buy
Price Target: $12 → $7
Current: $1.49
Upside: +369.83%
Jun 17, 2022
Maintains: Buy
Price Target: $23 → $25
Current: $109.88
Upside: -77.25%
Nov 15, 2021
Upgrades: Buy
Price Target: $12 → $16
Current: $8.34
Upside: +91.85%
Sep 7, 2021
Initiates: Buy
Price Target: $285
Current: $13.81
Upside: +1,963.72%
May 3, 2021
Initiates: Buy
Price Target: $20
Current: $2.97
Upside: +573.40%
Sep 8, 2020
Downgrades: Neutral
Price Target: n/a
Current: $18.50
Upside: -
Jun 17, 2020
Initiates: Neutral
Price Target: n/a
Current: $26.55
Upside: -
Jun 17, 2020
Initiates: Neutral
Price Target: n/a
Current: $6.76
Upside: -
Jun 17, 2020
Initiates: Buy
Price Target: $12
Current: $1.24
Upside: +867.74%
Oct 23, 2017
Maintains: Outperform
Price Target: $600 → $490
Current: $16.10
Upside: +2,943.48%